# GADD45GIP1

## Overview
GADD45GIP1, or growth arrest and DNA-damage-inducible gamma interacting protein 1, is a gene that encodes the protein GADD45G interacting protein 1, also known as CRIF1. This protein is primarily localized in the nucleus and is involved in critical cellular processes such as cell cycle regulation, apoptosis, and genomic stability. GADD45GIP1 interacts with the GADD45 family of proteins, playing a significant role in modulating cellular stress responses and maintaining genomic integrity. It functions as a negative regulator of cell cycle progression and cell growth, which is particularly relevant in the context of cancer, where its expression is inversely related to NAC1, a factor associated with tumor proliferation and chemotherapy resistance (Nakayama2017Nucleus; Jiang2022Multifunctions). Additionally, GADD45GIP1 is implicated in mitochondrial function, influencing oxidative phosphorylation, and is considered a potential therapeutic target for diseases characterized by mitochondrial dysfunction (Jiang2022Multifunctions).

## Function
GADD45GIP1, also known as GADD45γ-interacting protein 1, is involved in regulating cell cycle progression and apoptosis. It interacts with the GADD45 family of proteins, which are known to influence cellular stress responses. GADD45GIP1 is primarily active in the nucleus, where it modulates transcriptional activities and may play a role in maintaining genomic stability. This protein acts as a negative regulatory factor for cell cycle progression and cell growth, suggesting its involvement in controlling cellular proliferation (Nakayama2017Nucleus).

In the context of cancer, GADD45GIP1 expression is inversely related to NAC1 expression, a factor associated with tumor cell proliferation and chemotherapy resistance. When NAC1 is downregulated, GADD45GIP1 expression increases, which is linked to the promotion of cellular senescence, a state that can inhibit cancer cell growth (Nakayama2017Nucleus). This relationship highlights the potential role of GADD45GIP1 in cellular senescence and its importance in the response to cellular stress, particularly in the context of cancer treatment resistance (Nakayama2017Nucleus). While the specific function of GADD45GIP1 in healthy human cells is not directly addressed in the provided context, its involvement in cell cycle regulation and genomic stability suggests a critical role in normal cellular homeostasis.

## Clinical Significance
GADD45GIP1, also known as CRIF1, plays a significant role in cancer and mitochondrial dysfunction. Alterations in its expression are linked to paclitaxel resistance in ovarian cancer. Overexpression of NAC-1, which negatively regulates GADD45GIP1, is associated with increased resistance to paclitaxel, while knockdown of NAC-1 or overexpression of GADD45GIP1 enhances sensitivity to the drug. This suggests that targeting the NAC-1/GADD45GIP1 pathway could be a therapeutic strategy to overcome drug resistance in ovarian cancer (Jinawath2009NAC1).

CRIF1 is also implicated in the regulation of the cell cycle and mitochondrial function. It interacts with Gadd45 family proteins and CDK2, inhibiting CDK2 activity and causing cell cycle arrest, which is significant in cancer therapy. CRIF1's role in mitochondrial function, particularly in regulating oxidative phosphorylation, suggests its potential as a target for diseases characterized by impaired mitochondrial function, such as atherosclerosis, Alzheimer's, and diabetes mellitus type 2 (Jiang2022Multifunctions).

The involvement of CRIF1 in these pathways highlights its potential as a therapeutic target in cancer treatment, aiming to enhance the sensitivity of cancer cells to therapies (Jiang2022Multifunctions).

## Interactions
GADD45GIP1, also known as CRIF1, is involved in several protein interactions that play crucial roles in cellular processes. It interacts with the Gadd45 family proteins, including Gadd45α, Gadd45β, and Gadd45γ, enhancing their functions in cell cycle regulation and apoptosis. This interaction is significant in inhibiting Cdc2 kinase, which is essential for cell cycle checkpoints (Jiang2022Multifunctions). GADD45GIP1 also interacts with CDK2, inhibiting its activity and causing cell cycle arrest in the G0/G1 phase through specific amino acid residues that form an interface between the two proteins (Jiang2022Multifunctions).

In the context of ovarian cancer, NAC1 negatively regulates the expression of GADD45GIP1, contributing to chemoresistance. NAC1 binds directly to the promoter region of the GADD45GIP1 gene, repressing its transcriptional activity. This interaction involves the BEN domain of NAC1, which binds to a specific DNA sequence motif (Nakayama2020Nucleus). The suppression of GADD45GIP1 by NAC1 is linked to paclitaxel resistance, as NAC1 overexpression reduces GADD45GIP1 levels, thereby enhancing resistance to chemotherapy (Jinawath2009NAC1).

GADD45GIP1 is also associated with mitochondrial function, interacting with the large subunit of the mitoribosome and regulating oxidative phosphorylation capacity (Jiang2022Multifunctions).


## References


[1. (Jinawath2009NAC1) N Jinawath, C Vasoontara, K-L Yap, M M Thiaville, K Nakayama, T-L Wang, and I-M Shih. Nac-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating gadd45 pathway. Oncogene, 28(18):1941–1948, March 2009. URL: http://dx.doi.org/10.1038/onc.2009.37, doi:10.1038/onc.2009.37. This article has 72 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/onc.2009.37)

[2. (Nakayama2020Nucleus) Naomi Nakayama, Gyosuke Sakashita, Takashi Nagata, Naohiro Kobayashi, Hisashi Yoshida, Sam-Yong Park, Yuko Nariai, Hiroaki Kato, Eiji Obayashi, Kentaro Nakayama, Satoru Kyo, and Takeshi Urano. Nucleus accumbens-associated protein 1 binds dna directly through the ben domain in a sequence-specific manner. Biomedicines, 8(12):608, December 2020. URL: http://dx.doi.org/10.3390/biomedicines8120608, doi:10.3390/biomedicines8120608. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biomedicines8120608)

[3. (Nakayama2017Nucleus) Kentaro Nakayama, Munmun Rahman, Mohammed Tanjimur Rahman, Kohei Nakamura, Emi Sato, Hiroshi Katagiri, Tomoka Ishibashi, Masako Ishikawa, Kouji Iida, Sultana Razia, Noriyuki Ishikawa, and Satoru Kyo. Nucleus accumbens-1/gadd45gip1 axis mediates cisplatin resistance through cellular senescence in ovarian cancer. Oncology Letters, 13(6):4713–4719, April 2017. URL: http://dx.doi.org/10.3892/ol.2017.6099, doi:10.3892/ol.2017.6099. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2017.6099)

[4. (Jiang2022Multifunctions) Yangzhou Jiang, Yang Xiang, Chuanchuan Lin, Weiwei Zhang, Zhenxing Yang, Lixin Xiang, Yanni Xiao, Li Chen, Qian Ran, and Zhongjun Li. Multifunctions of crif1 in cancers and mitochondrial dysfunction. Frontiers in Oncology, October 2022. URL: http://dx.doi.org/10.3389/fonc.2022.1009948, doi:10.3389/fonc.2022.1009948. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2022.1009948)